[CYCC] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -37.29%
YoY- 15.32%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 0 150 0 0 0 0 0 -
PBT -2,110 -2,370 -2,369 -2,354 -1,531 -2,071 -2,076 1.08%
Tax -268 -352 -301 -502 -182 -200 -219 14.42%
NP -1,842 -2,018 -2,068 -1,852 -1,349 -1,871 -1,857 -0.53%
Tax Rate - - - - - - - -
Total Cost 1,842 2,168 2,068 1,852 1,349 1,871 1,857 -0.53%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 0.00 -1,345.33 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -2.70 -2.96 -3.45 -3.09 -2.25 -3.14 -3.78 -20.11%
EPS Diluted -2.70 -2.96 -3.45 -3.09 -2.25 -3.12 -3.78 -20.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.